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oninvasive Characterization of Myocardial
olecular Interventions by Integrated Positron
mission Tomography and Computed Tomography
ettina Wagner, DVM,* Martina Anton, PHD,† Stephan G. Nekolla, PHD,* Sybille Reder, MT,*
ulia Henke, DVM,† Stefan Seidl, MD,‡ Renate Hegenloh, MT,§ Masao Miyagawa, MD,*
oland Haubner, PHD,* Markus Schwaiger, MD,* Frank M. Bengel, MD*
unich, Germany; and Baltimore, Maryland
OBJECTIVES We sought to investigate the usefulness of integrated positron emission tomography (PET)
and computed tomography (CT) for in vivo characterization of an angiogenesis-directed
molecular intervention.
BACKGROUND Controversies about the effectiveness of molecular therapies for cardiovascular disease have
prompted the need for more powerful noninvasive imaging techniques.
METHODS In a model of regional adenoviral transfer of the VEGF121 gene to myocardium of healthy
pigs, PET-CT using multiple molecular-directed radiotracers was employed.
RESULTS Two days after gene transfer, successful transgene expression was noninvasively confirmed by
a reporter probe targeting co-expressed HSV1-sr39tk reporter gene. The CT-derived
ventricular function and morphology remained unaltered (left ventricular ejection fraction
57  5% in adenovirus-injected animals vs. 53  5% in controls; p  0.36). Increased
regional perfusion was identified in areas overexpressing VEGF (myocardial blood flow
during adenosine-induced vasodilation 1.47 0.49 vs. 1.14 0.27 ml/g/min in remote areas;
p  0.01), corroborating in vivo effects on microvascular tone and permeability. Finally,
regional angiogenesis-associated v3 integrin expression was not enhanced, suggesting little
contribution to the perfusion increase. Fusion of CT morphology and tracer-derived
molecular signals allowed for accurate regional localization of biologic signals. Findings were
validated by control vectors, sham-operated animals, and ex vivo tissue analysis.
CONCLUSIONS Integrated PET-CT has the potential to dissect cardiovascular biologic mechanisms from
gene expression to physiologic function and morphology. The VEGF overexpression in
healthy myocardium increases myocardial perfusion without significant up-regulation of v3
integrin adhesion molecules early after the intervention. (J Am Coll Cardiol 2006;48:
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.08.0292107–15) © 2006 by the American College of Cardiology Foundation
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tarious gene- and cell-based molecular therapeutic ap-
roaches directed against cardiovascular disease have been
valuated in experimental settings, and some have reached
he stage of clinical trials (1,2). Despite rapid progress, some
asic principles of these therapies are still under develop-
ent, and issues related to therapeutic efficacy and the best
elivery of agents to myocardium are still debated. For
xample, early experimental results for angiogenesis therapy
f myocardial ischemia were difficult to reproduce in the
linical setting (3,4).
These developments have prompted a need for powerful
oninvasive imaging tools to provide specific disease-related
iologic insights and facilitate the translation from experi-
ental to clinical practice. A single cardiac imaging modal-
ty for in vivo characterization of tissue biology, physiologic
From the *Nuklearmedizinische Klinik und Poliklinik, †Institut für Experimentelle
nkologie und Therapieforschung, ‡Institut für Allgemeine Pathologie und Patholo-
ische Anatomie, and §Abteilung für Gefäßchirurgie, Technische Universität
ünchen, Germany; and the Division of Nuclear Medicine, Johns Hopkins
niversity, Baltimore, Maryland. Supported by a grant from the Deutsche For-u
chungsgemeinschaft (Be 2217/4-1).
Manuscript received July 31, 2006, accepted August 30, 2006.unction, and morphologic appearance could thus be of
onsiderable value.
In the present study, we explored the potential of inte-
rated positron emission tomography (PET) and computed
omography (CT) for noninvasive imaging of a myocardial
olecular intervention (i.e., the regional transfer of vascular
ndothelial growth factor [VEGF] gene to myocardium of
ealthy pigs). Our primary goal was to study the feasibility
f this methodology for integrated imaging of the heart
rom its morphology to subcellular function. As a secondary
oal, we intended to get further insights into the effects of
EGF overexpression on the tissue level and on the heart as
whole.
ETHODS
xperimental protocol. The experimental protocol was
pproved by the regional governmental commission of
nimal protection (Regierung von Oberbayern) and is sum-
arized in Table 1.
Eleven young domestic pigs (30 to 40 kg; Versuchssta-
ion, Thalhausen, Germany) underwent left thoracotomy
nder anesthesia with mechanical ventilation (10 mg/kg/h
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Molecular Myocardial PET-CT November 21, 2006:2107–15ropofol intravenously, fentanyl intravenously as required).
ericardium was opened, and gene transfer was performed
n study group animals (n  8) using doses of 1  1010
laque-forming units (pfu) of adenovirus (total volume 1
l, aliquoted into 5 syringes). Those were consecutively
njected into 2 separate myocardial areas of approximately 2
cm. Control group animals (n  3) received saline injection
ollowing the same protocol. Both injection sites were marked
ith titanium clips (LIGACLIP 20/20, Ethicon, Norderstedt,
ermany).
Two days later, all pigs were anesthetized using the same
egimen and underwent PET-CT. Animals were killed after
maging (60 mg/kg sodium pentobarbital intravenously).
earts were excised and rinsed, and transmural tissue
amples were taken from the 2 areas of injection and from
remote area (inferior wall).
Abbreviations and Acronyms
Adsr39tk  replication defective type 5 adenovirus
expressing a mutant herpesviral thymidine
kinase reporter gene
AdTk-VEGF  replication defective type 5 adenovirus co-
expressing a mutant herpesviral thymidine
kinase reporter gene and the human
VEGF121 gene
AdVEGF  replication defective type 5 adenovirus
expressing the human VEGF121 gene
CT  computed tomography
FHBG  [18F]fluoro-hydroxymethylbutyl-guanine
MBF  myocardial blood flow
PET  positron emission tomography
VEGF  vascular endothelial growth factor
able 1. Animals and Study Protocol
Animal
LV Myocardial
Injection Site
PET-CT Protocol
Basal
Anterior
Distal
Anterolateral
1 AdTk-VEGF Adsr39tk Study group, day 2
2 Adsr39tk AdTk-VEGF Contrast enhanced CT
3 AdTk-VEGF AdVEGF 2 [
13N]-ammonia perfusion
PET
4 AdVEGF AdTk-VEGF [
18F]-FHBG reporter gene
PET
5 AdTk-VEGF Adsr39tk 2
nd session (animals 5–8,
day 3–9)
6 Adsr39tk AdTk-VEGF Contrast enhanced CT
7 AdTk-VEGF AdVEGF [
13N]-ammonia perfusion
PET
8 AdVEGF AdTk-VEGF [
18F]-galacto-RGD PET
9 Saline Saline Control group, day 2
10 Saline Saline Contrast enhanced CT
11 Saline Saline 2 [13N]-ammonia perfusion
PET
dsr39tk  adenovirus expressing mutant herpesviral thymidine kinase reporter gene;
dTk-VEGF  adenovirus coexpressing mutant herpesviral thymidine kinase reporter
ene and vascular endothelial growth factor 121 gene; AdVEGF  adenovirus
xpressing vascular endothelial growth factor 121 gene; CT computed tomography;[
HBG  fluoro-hydroxymethylbutyl-guanine; LV  left ventricular; PET 
ositron emission tomography.denoviral vector preparation and injection. E1 region-
eleted replication-deficient adenoviral vectors carrying
ransgenes under transcriptional control of human cytomeg-
lovirus promoter were used. Vectors were double cesium
hloride purified. Titers were determined by plaque assay on
93 cells. For monitoring of therapeutic gene expression by
o-expression of a reporter gene, adenovirus expressing the
utant herpesviral thymidine kinase (HSV1-sr39tk) re-
orter gene and the human VEGF121 gene independently in
expression cassettes (AdTk-VEGF) (5) was applied in all
pigs. The injection site (basal or apical) was varied to
ontrol for interfering effects (Table 1). For injection into the
econd site, control adenovirus expressing only 1 transgene,
ither the HSV1-sr39tk reporter gene (Adsr39tk; n 4), or the
EGF121 gene (AdVEGF; n  4), was used.
ET-CT imaging protocol. Imaging was done on a Sie-
ens Biograph Sensation 16 scanner (Siemens Medical Solu-
ions, Malvern, Pennsylvania), a hybrid system incorporating a
6-slice X-ray CT and a 3D LSO crystal-equipped PET
omponent. [18F]fluoro-hydroxymethylbutyl-guanine
FHBG) and [18F]galacto-RGD were synthesized as previ-
usly described (6,7).
All animals were scanned in supine position under anes-
hesia with mechanical ventilation. Heart rate, blood oxygen
aturation, and electrocardiogram were recorded continu-
usly. Imaging sessions started with an X-ray topogram for
rientation, followed by a low-dose CT (tube voltage
20 kV, tube current 14 mA) of the cardiac region for
ubsequent correction for photon attenuation. Ventilation
as temporarily stopped for CT to obtain images in an
ntermediate breathing position for improved alignment
etween CT and PET.
Subsequently, PET emission data were obtained. Myo-
ardial perfusion was assessed by use of [13N]ammonia. At
est, 185 to 240 MBq were injected intravenously, and a
0-min dynamic acquisition in list mode, immediately
ollowed by a static image of 10 min, was acquired. After a
reak of 30 min to allow for decay, pharmacologic vasodilation
as induced by infusion of adenosine (0.14 mg/kg/min) for 5
inutes. Two minutes into the adenosine infusion, a second
ose of [13N]ammonia was injected and another set of
mages was obtained. In the 8 animals that received adeno-
iral vectors, 160 to 260 MBq of [18F]FHBG were then
njected, and a 20-min static image was obtained 45 min
fter injection.
After PET, the session was concluded with contrast-
nhanced CT. Imaging of a test bolus of 20 ml contrast
gent (Imeron300, Altana Pharma, Konstanz, Germany)
as performed. Then mechanical respiration was stopped
gain, 70 ml contrast agent was injected at 4 ml/s, and a
olume data set was acquired (tube voltage 100 kV, tube
urrent 550 mA), covering the entire cardiac region with
ontinuous electrocardiogram co-registration.
Four animals underwent a second PET-CT session at day
to 9 after surgery. This session consisted of CT, a13N]ammonia perfusion measurement at rest, as described
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November 21, 2006:2107–15 Molecular Myocardial PET-CTn the preceding, and injection of 170 to 215 MBq
18F]galacto-RGD and a 30-min static image after 60 min.
ET data analysis. Attenuation-corrected transaxial im-
ges were reconstructed by an iterative algorithm (OSEM,
iterations, 8 subsets, 128  128 matrix, slice thickness
mm, no overlap). Using in-house-developed software
Munich Heart) (8), volumetric sampling was performed to
dentify 460 myocardial segments in the resting perfusion
tudy of each session. For precise regional co-localization,
egments were then transferred to images of stress perfusion
nd [18F]FHBG and [18F]galacto-RGD distribution. Polar
aps of left ventricular myocardial uptake for each tracer
ere generated and normalized. Regional tracer uptake was
xpressed as percentage of the maximum in 9 myocardial
reas (anterior, lateral, septal, and inferior wall, divided in
asal and distal areas; apex as separate area). The 2 injection
reas along with a remote area were defined according to the
xperimental protocol and according to localization of
itanium clip markers at CT.
Absolute quantification of myocardial blood flow (MBF)
as performed by use of dynamic [13N]ammonia datasets,
ased on a validated three-compartment model (9). List
ode data were rebinned to 18 consecutive dynamic image
atasets (12  10 s, 4  60 s, 2  120 s). Arterial input
igure 1. Assessment of morphology and contractile function. (A) Contr
ositron emission tomography–CT in an animal (animal 5; Table 1) after
aline injection (bottom). Surface-rendered images (left, anterior view) allo
istal anterolateral wall (arrows). Ventricular function is determined from end-d
) Mean  SD of regional end-diastolic wall thickness and thickening.unction was defined by a small region of interest in left
entricular cavity. Motion-corrected time activity curves
ere extracted for the 460 myocardial segments previously
efined from static images. The MBF in ml/g/min was
alculated for each segment by compartment-model fitting
nd depicted in a polar map.
T image analysis. For contrast-enhanced CT, overlap-
ing transaxial images were reconstructed using a
edium-smooth convolution kernel (B30f, 512  512
atrix, slice thickness 1 mm, increment 0.7 mm). Image
econstruction was retrospectively gated to the electro-
ardiogram. The reconstruction window was varied with
10% increment, and 10 datasets covering the cardiac
ycle in different phases were obtained. Artifact-free data
ets were chosen for volume-rendered display and
oftware-based overlay with PET. Data sets for all 10
hases were re-angulated perpendicular to the left ven-
ricular long axis. Using in-house-developed software
Munich Heart), endocardial and epicardial contours
ere drawn in end-systolic and end-diastolic short-axis
lices. The left ventricular ejection fraction (LVEF) was
btained, and regional end-diastolic and end-systolic wall
hickness and thickening were calculated for clip-marked
njection sites and a remote area in inferior wall. The
hanced multislice computed tomographic (CT) images obtained during
oviral gene transfer (top) and a control animal (animal 10; Table 1) after
accurate identification of clip-marked injection sites in basal anterior andast-en
aden
w foriastolic (middle right) and end-systolic short-axis images (right). (B and
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Molecular Myocardial PET-CT November 21, 2006:2107–15ET-CT fusion images were generated following manual
eadjustment, using standard software provided by the
anufacturer.
easurement of plasma VEGF concentration. Blood
amples were taken before surgery and 6, 30, and 48 h after
he surgical intervention. Plasma levels of human VEGF
ene product were measured using a VEGF enzyme-linked
mmunosorbent assay kit (Calbiochem, Schwalbach,
ermany).
istology and immunohistochemistry. Formalin-fixed
yocardial specimens were embedded in paraffin. For qual-
tative histologic examination of vascular/capillary density,
araffin sections (2 m) were stained according to van
ieson. For immunohistochemistry, sections were deparaf-
nized, dehydrated, and pressure-cooked in citrate buffer,
ollowed by blocking of endogenous peroxidase (3%
2O2/methanol).
Immunostaining for transgene products used streptavidin-
orseradish-peroxidase technique with incubation of slides
ith polyclonal rabbit anti–HSV1-tk or anti-humanVEGF
ntibody and consecutively with ready-to-use anti-rabbit
ntibody (Dako ChemMate Detection Kit K5001; Dako-
ytomation, Hamburg, Germany).
Immunostaining for microvascular density used the
PAAP technique (DAKO Chem Mate Detection Kit
PAAP, Mouse). Primary antibody against alpha smooth
uscle actin (DAKOCytomation Clone 1A4, 70 mg/l, 1:50
iluted) was used. For quantification, 10 high-power fields
HPF) from a representative slice of vector-injected regions
ere microscopically analyzed, and small vascular structures
ere counted.
tatistical analysis. Data were analyzed with StatView5.0
oftware (SAS Institute, Cary, North Carolina). Values are
xpressed as mean  SD. Differences were assessed by
aired/unpaired t test as appropriate or (for multiple com-
arisons) by 1-way analysis of variance with the Fisher
enalized least square of differences post hoc test. A 2-sided
value of 0.05 was defined as significant.
ESULTS
T identifies cardiac intervention sites and preserved
tructure and function. Titanium clip markings were re-
iably identified in all animals (Fig. 1A), allowing for fusion
nd co-localization with PET-derived biologic images.
lobal LVEF was normal in all animals. There was no
ifference between adenovirus-injected animals and saline-
njected control animals (57  5% vs. 53  5%; p  0.36).
onsistently, regional contractile function was homoge-
eous. There was no difference for regional wall thickening
etween adenovirus-injected, saline-injected, or noninjected
reas (p  0.73) (Fig. 1C). Absolute end-diastolic wall
hickness was also not different between regions (p  0.70)
Fig. 1B).
[
aET reporter gene imaging and PET-CT image fusion
dentify successful gene transfer and regional transgene
xpression. All sites injected with adenoviral vector encod-
ng for HSV1-sr39tk reporter gene (AdTk-VEGF or Adsr39tk)
evealed significantly elevated uptake of FHBG compared
ith AdVEGF-injected or remote areas (p 0.01) (Fig. 2A).
ncreased regional uptake co-localized with titanium clip
arkings (Figs. 3A and 3B). in vivo results were confirmed
y ex vivo immunohistochemistry. Expression of HSV1-
r39tk gene product was identified in cytosol and nuclei of
igure 2. Uptake of tracers of myocardial reporter gene expression and
erfusion in regions of adenoviral gene transfer (AdTk-VEGF [n  8];
dVEGF [n  4]; Adsr39tk [n  4]; remote [n  8]). (A) Regional uptake
f the reporter probe [18F]fluoro-hydroxymethylbutyl-guanine (FHBG).
p  0.01 vs. AdVEGF and remote. (B) Regional uptake of the perfusion
racer [13N]ammonia at rest. *p  0.01 vs. Adsr39tk and remote. (C)
13N]ammonia uptake during adenosine vasodilation. *p 0.01 vs. Adsr39tk
nd remote). Bars indicate mean  SD.
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November 21, 2006:2107–15 Molecular Myocardial PET-CTyocardial cells in areas injected with AdTk-VEGF or
dsr39tk. Immunostaining for VEGF was positive in the
ytosol of myocardial cells in areas injected with AdTk-VEGF
r AdVEGF (Fig. 4).
Further support for successful transgene expression was
btained by the appearance of the secretable gene product
EGF121 in the systemic circulation. Human VEGF was
ot detectable in saline-injected animals, nor was it detect-
ble in blood samples before adenoviral injection. After gene
igure 3. Positron emission tomography (PET)–computed tomographic (C
mages are shown. (A) Study animal (animal 1; Table 1) after regional injec
ene (AdTk-VEGF, top row), or HSV1-sr39tk reporter gene only (Adsr39t
njection of AdTk-VEGF (top row). This time, virus expressing VEGF121
animal 9; Table 1) after regional injection of saline at both sites. Column
rientation of short-axis slices, along with injection sites (yellow) is shown;
yellow arrows), along with circumferential wall thickness; next, PET
18F]fluoro-hydroxymethylbutyl-guanine (FHBG) show significant accum
SV1-sr39tk reporter gene (animal A, both rows; animal B, top row)
asodilation show significantly elevated [13N]ammonia uptake at sites wher
t is regionally homogeneous after Adsr39tk injection (animal A, bottom roransfer, the gene product appeared in the blood of all Aector-injected animals, peaked (755  946 pg/ml) at 6 h,
eclined (385  783 pg/ml) by 30 h, and was detectable in
nly 1 animal at 48 h after gene transfer.
ET-CT identifies enhanced relative and absolute per-
usion after VEGF gene transfer. There was a significant
ncrease of relative uptake of [13N]ammonia in VEGF-
ransduced areas after injection of either AdTk-VEGF or
dVEGF (p 0.01 vs. AdVEGF and remote areas) (Figs. 2B,
C, 3A, and 3B). No differences were found between
aging of morphology and biology. Representative short-axis tomographic
f adenovirus carrying HSV1-sr39tk reporter gene together with VEGF121
ttom row). (B) Another study animal (animal 3; Table 1) after regional
as used as internal control (AdVEGF, bottom row). (C) Control animal
left to right: on the left, a schematic display of individual location and
ontrast-enhanced multislice CT depicts location of titanium clip markings
fusion of morphologic CT with PET images of the reporter probe
on of FHBG, colocalizing with clip markings in areas expressing the
the right, PET perfusion images at rest and during adenosine-induced
F121 is overexpressed (animal A, top row; animal B, both rows), whereas
r saline injection (animal C).T) im
tion o
k, bo
only w
s from
next, c
-CT
ulati
; on
e VEGdsr39tk-injected and noninjected control areas. All saline-
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Molecular Myocardial PET-CT November 21, 2006:2107–15njected control animals showed regionally homogeneous
erfusion, ruling out procedure-related influences (Fig. 3C).
Because regionally increased relative uptake of [13N]am-
onia in static PET images may occur because of increased
ascular permeability without a true increase of absolute
issue perfusion, we additionally explored quantitative MBF
rom dynamic images. At intraindividual comparison, MBF
t rest in study animals was not significantly different
etween areas injected with AdTk-VEGF and remote areas
0.85  0.22 vs. 0.78  0.13 ml/g/min; p  0.19). During
igure 4. Ex vivo immunohistochemical staining of transgene products. Sh
njected with adenovirus carrying HSV1-sr39tk reporter gene together with
EGF (B and D) was performed in adjacent slices. Dark brown color in
hows corresponding expression of both transgene products in the same tis
roduct in cytosol and nuclei, whereas VEGF is found in cytosol only
ocalization of the immunostaining signal are explained by gene product
ubstance).
igure 5. Ex vivo immunohistochemical staining of microvessels. Pink colo
hown are microscopic images of samples from a myocardial area injected
f the same animal injected with adenovirus carrying HSV1-sr39tk reporter gene
ensity is present in the VEGF-exposed area.denosine vasodilation, MBF was significantly higher com-
ared with remote areas (1.47  0.49 vs. 1.14  0.27
l/g/min; p  0.01). Overall, MBF in vector-injected
nimals was in the range of MBF measured in respective
egions of sham-operated animals (0.75 ml/g/min at rest and
.31 during adenosine), when compared interindividually.
Postmortem analysis revealed mildly, but significantly,
nhanced microvascular density in areas injected with
EGF-expressing vector (5.57  2.15 microvessels/HPF vs.
.17  1.11 for Adsr39tk-injected areas; p  0.03) (Fig. 5).
are microscopic images of a representative sample from a myocardial area
EGF121 gene (AdTk-VEGF). Immunostaining for HSV1-tk (A and C) and
s presence of the respective gene product. Low magnification (A and B)
gion. High magnification (C and D) identifies HSV1-tk reporter gene
ly in a vesicle-like pattern. Subtle differences in strength and cellular
acteristics (HSV1-TK is an intracellular enzyme, VEGF is a secretable
icates presence of smooth muscle actin (small vessels indicated by arrows).
adenovirus carrying HSV1-sr39tk only (Adsr39tk) (A), and of another areaown
the V
dicate
sue re
, partr ind
withtogether with the VEGF121 gene (AdTk-VEGF) (B). Higher microvascular
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November 21, 2006:2107–15 Molecular Myocardial PET-CTEGF-induced regional perfusion increase is not asso-
iated with up-regulation of v3 integrin. The second
ET-CT session at 3 to 9 days after the intervention
ocused on measurement of v3 integrin expression. Per-
usion tracer uptake was again measured at rest, and was still
ignificantly elevated in regions overexpressing VEGF (80
% vs. 63  8% in remote areas; p  0.002), confirming
ersistence of vascular effects.
Overall myocardial uptake of the v3 integrin-targeted
racer [18F]-galacto-RGD was very low, and no focal uptake
as detected in regions of VEGF overexpression showing
ncreased perfusion (Fig. 6). Relative regional uptake was
ot different from remote areas (72  5% vs. 75  9%;
 0.45).
ISCUSSION
n summary, the present study demonstrates that integrated
ET-CT can be used to get detailed in vivo insights into
iologic mechanisms of the heart. Changes induced by
olecular intervention were characterized from gene ex-
ression over physiologic changes to morphologic appear-
nce. Successful adenoviral transfer and subsequent expres-
ion of target gene (VEGF121) in myocardium was
pecifically identified by PET imaging of a co-expressed
eporter gene, which co-localized with clip-marked myocar-
ial injection sites detected by CT. With the help of CT
o-localization, specific effects of target gene overexpres-
ion on myocardial microcirculation at rest and during
asodilation were then characterized by quantitative per-
usion imaging. The same technique also suggested that
v3 integrins do not play a role in the early phase of this
EGF-induced increase of myocardial perfusion in healthy
yocardium. Finally, co-registration of CT further added to
ET-determined biologic data by defining morphology and
igure 6. Positron emission tomography (PET)–computed tomographic (
hrough injection sites receiving adenovirus carrying the HSV1-sr39tk repo
hich underwent a repeat PET-CT session at 3 (top, animal 5; Table 1)
multislice computed tomography [MSCT], left) depict location of titaniu
SCT with PET images of the perfusion tracer [13N]ammonia at re
13N]ammonia at the site of AdTk-VEGF injection. PET images of [
18F]-gonfirming absence of impairments of contractile function. nhese findings establish an imaging modality with substan-
ial future potential in development and monitoring of
ardiovascular therapy.
Integrated PET-CT has reportedly been useful for clin-
cal imaging of myocardial perfusion and viability (10–13).
he present study goes into further detail and demonstrates
he feasibility of molecular characterization of the heart by
ntegrating information from multiple PET tracers and
ontrast-enhanced CT. It is suggested that PET-CT has
ubstantial potential as a translational tool that can be
pplied in experimental models as well as in clinical practice.
or future clinical application, issues related to radiation
xposure by combined nuclear and X-ray techniques need to
e considered, and short-lived PET tracers will still require
n on-site cyclotron for production. But it can be expected
hat localization and interpretation of the often weak
pecific signal from molecular-targeted PET probes will be
acilitated by co-registration with high-resolution cardiac
T. Although fusion of PET and CT data had to be
isually realigned in this study owing to potential influences
f respiratory and cardiac motion, algorithms that allow for
egistration of respiratory motion during imaging are under
evelopment. These are expected to improve the precision
f spatial co-registration in the future (14) and may help to
ircumvent problems with faulty attenuation correction of
ET data from potentially misaligned CT scans to extend
he application of PET-CT beyond myocardial imaging
oward biomorphologic imaging of coronary vessels in the
uture.
Although proof of principle for the usefulness of
ET-CT as a cardiac molecular imaging tool was the
rimary goal of this study, we chose a model of VEGF
yocardial gene transfer, which allowed for using the novel
maging approach to get further insights into the mecha-
imaging of integrin expression. Shown are representative short-axis slices
ene together with the VEGF121 gene (AdTk-VEGF) in 2 different animals
(bottom, animal 7; Table 1) days after adenovirus injection. CT images
markings of injection sites (yellow arrows). Middle left shows fusion of
T perfusion images (middle right) show significant accumulation of
-RGD (right) show no accumulation at vector injection sites.CT)
rter g
or 9
m clipisms and consequences of VEGF overexpression. This
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Molecular Myocardial PET-CT November 21, 2006:2107–15odel was chosen because it has been considered promising
or angiogenesis therapy of myocardial ischemia (2). Diffi-
ulties with this therapy were encountered when trying to
eproduce experimental results in clinical trials (3,4), em-
hasizing the need for a more detailed understanding of
herapeutic mechanisms and for more specific techniques to
onitor success. To avoid the complexity and interindi-
idual heterogeneity associated with animal models of
yocardial ischemia, we chose for this initial methodologic
valuation to study effects of VEGF gene transfer in a stable
odel of surgical injection into healthy myocardium. Our
esults show that VEGF, when successfully overexpressed in
ormal heart muscle, increases regional myocardial perfu-
ion. The CT morphology helped in accurately identifying
he area of intervention and in localization of perfusion
ncrease. It is tempting to speculate that lack of morphologic
nformation to accurately identify injection sites may have
esulted in a lack of observation of physiologic in vivo effects
f gene transfer in a previous study with stand-alone
icroPET (15).
Interestingly, expression of v3 integrins did not seem to
lay a role in the VEGF-induced increase of perfusion early
fter gene transfer in our study. v3 Integrin is a group of
dhesion molecules which has been targeted previously by
olecular imaging as playing a role in post-myocardial
nfarction angiogenesis (16). The tracer used in the present
tudy has been extensively validated as a marker of v3
ntegrin expression in previous studies (7,17,18).
The sum of the effects of VEGF on healthy myocardium
bserved in the present study are most likely explained as
ollows. Our imaging studies were performed a few days
fter adenoviral gene transfer, at a time when expression of
ransgenes is known to be highest. Tissue levels of VEGF
herefore reached a peak at this early time. Vascular endo-
helial growth factor is known to be a potent vasodilator,
ecause it activates endothelial nitric oxide synthase and
hus increases nitric oxide (NO) levels (19). Additionally,
EGF is known to increase vascular permeability through
ormation of intercellular gaps, vacuoles, and fenestrations,
n effect partially mediated via NO release (20). The
bserved increase of perfusion at rest and during pharma-
ologic vasodilation is therefore most likely explained by
hese direct effects of overexpressed VEGF on the micro-
asculature. Vasodilation and increased microvascular
enisty have also recently been established as important
O-mediated precursors of angiogenesis (21). Significant
mounts of new blood vessel are not expected to have
ormed at this early time, and the mild increase of histologic
icrovascular density may be associated with vasodilation
nd thus improved detectability of microvessels. Expression
f integrin adhesion molecules may not yet play a role or
ay require the strong stimulus of ischemic myocardial
amage suggested in previous studies (16) for detectability,
hich was not present in our setup of healthy myocardium.
lthough this hypothesis for an underlying mechanism of
ur observations is at present speculative, it will be interest-ng to determine its validity in future molecular imaging
tudies of disease models. Notably, quantitatively assessed
lobal microvascular reactivity was low (ratio stress/rest
BF 2) compared with values obtained in other animal
nd human studies. But this observation was true for
ector-injected and sham-operated animals. It is therefore
ot specific for the molecular intervention and may rather be
ttributed to surgical or anesthetic procedure.
In conclusion, our study provides proof of feasibility for
ntegrated multislice PET-CT to dissect cardiac biologic
echanisms following a molecular intervention. The tech-
ique seems ready for serial application in other animal
odels and models of cardiac disease or new therapies.
ascular endothelial growth factor gene transfer, or novel
efined techniques for angiogenesis gene therapy (e.g., more
omplex models of short- and long-term ischemia) can be
valuated repetitively at different stages, and the obtained
iologic and morphologic data may help in refining the
linical usefulness of therapy. Similarly, other molecular
herapeutic approaches in the fields of cardiac gene therapy,
ell transplantation, or tissue engineering can be evaluated
oninvasively using this powerful biomorphologic imaging
echnique.
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